Trial Outcomes & Findings for Cognitive Rehabilitation for PD (NCT NCT03335150)

NCT ID: NCT03335150

Last Updated: 2021-02-23

Results Overview

The WAIS-IV Matrix Reasoning test is a validated, objective measure of executive function. Scaled scores range from 0 to 26. Higher scores indicate better executive function. Scores reported below are change scores.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

110 participants

Primary outcome timeframe

Baseline and Week 10

Results posted on

2021-02-23

Participant Flow

Participant milestones

Participant milestones
Measure
Supportive Care
Support Group for PD Supportive Care: Support Group for persons with PD
CogSMART-PD
Cognitive Rehabilitation for PD CogSMART-PD: Cognitive Rehabilitation for persons with PD
Overall Study
STARTED
55
55
Overall Study
Enrolled + Assigned Group
54
55
Overall Study
PRE Testing Session
53
55
Overall Study
Commenced Group
47
52
Overall Study
POST Testing Session
45
50
Overall Study
COMPLETED
45
50
Overall Study
NOT COMPLETED
10
5

Reasons for withdrawal

Reasons for withdrawal
Measure
Supportive Care
Support Group for PD Supportive Care: Support Group for persons with PD
CogSMART-PD
Cognitive Rehabilitation for PD CogSMART-PD: Cognitive Rehabilitation for persons with PD
Overall Study
Withdrawal by Subject
10
4
Overall Study
Adverse Event
0
1

Baseline Characteristics

54 subjects were enrolled for the Supportive Care group. 1 subject was missing the information.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Supportive Care
n=54 Participants
Support Group for PD Supportive Care: Support Group for persons with PD
CogSMART-PD
n=55 Participants
Cognitive Rehabilitation for PD CogSMART-PD: Cognitive Rehabilitation for persons with PD
Total
n=109 Participants
Total of all reporting groups
Age, Continuous
70.59 years
STANDARD_DEVIATION 7.06 • n=54 Participants
68.22 years
STANDARD_DEVIATION 7.98 • n=55 Participants
69.39 years
STANDARD_DEVIATION 7.60 • n=109 Participants
Sex: Female, Male
Female
20 Participants
n=54 Participants
12 Participants
n=55 Participants
32 Participants
n=109 Participants
Sex: Female, Male
Male
34 Participants
n=54 Participants
43 Participants
n=55 Participants
77 Participants
n=109 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants
n=54 Participants
3 Participants
n=55 Participants
7 Participants
n=109 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
50 Participants
n=54 Participants
52 Participants
n=55 Participants
102 Participants
n=109 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=54 Participants
0 Participants
n=55 Participants
0 Participants
n=109 Participants
Race/Ethnicity, Customized
Race · American Indian or Alaskan Native
0 Participants
n=54 Participants
0 Participants
n=55 Participants
0 Participants
n=109 Participants
Race/Ethnicity, Customized
Race · Asian
1 Participants
n=54 Participants
0 Participants
n=55 Participants
1 Participants
n=109 Participants
Race/Ethnicity, Customized
Race · Black or African American
1 Participants
n=54 Participants
2 Participants
n=55 Participants
3 Participants
n=109 Participants
Race/Ethnicity, Customized
Race · Hispanic or Latino
2 Participants
n=54 Participants
3 Participants
n=55 Participants
5 Participants
n=109 Participants
Race/Ethnicity, Customized
Race · Native Hawaiian or Pacific Islander
1 Participants
n=54 Participants
1 Participants
n=55 Participants
2 Participants
n=109 Participants
Race/Ethnicity, Customized
Race · White or Caucasian
49 Participants
n=54 Participants
49 Participants
n=55 Participants
98 Participants
n=109 Participants
Education
16.15 years
STANDARD_DEVIATION 2.41 • n=54 Participants
15.8 years
STANDARD_DEVIATION 2.29 • n=55 Participants
15.97 years
STANDARD_DEVIATION 2.34 • n=109 Participants
Duration of Disease
69.02 months
STANDARD_DEVIATION 55.97 • n=53 Participants • 54 subjects were enrolled for the Supportive Care group. 1 subject was missing the information.
73.27 months
STANDARD_DEVIATION 45.43 • n=55 Participants • 54 subjects were enrolled for the Supportive Care group. 1 subject was missing the information.
71.18 months
STANDARD_DEVIATION 50.68 • n=108 Participants • 54 subjects were enrolled for the Supportive Care group. 1 subject was missing the information.
Cognitive Status
Normal Cognition
14 Participants
n=54 Participants • 55 subjects were enrolled into the CogSMART-PD group; however, 1 participant did not meet inclusion criteria.
9 Participants
n=54 Participants • 55 subjects were enrolled into the CogSMART-PD group; however, 1 participant did not meet inclusion criteria.
23 Participants
n=108 Participants • 55 subjects were enrolled into the CogSMART-PD group; however, 1 participant did not meet inclusion criteria.
Cognitive Status
Mild Cognitive Impairment
40 Participants
n=54 Participants • 55 subjects were enrolled into the CogSMART-PD group; however, 1 participant did not meet inclusion criteria.
45 Participants
n=54 Participants • 55 subjects were enrolled into the CogSMART-PD group; however, 1 participant did not meet inclusion criteria.
85 Participants
n=108 Participants • 55 subjects were enrolled into the CogSMART-PD group; however, 1 participant did not meet inclusion criteria.
Motor Symptoms
12.28 seconds
STANDARD_DEVIATION 4.85 • n=51 Participants • 54 subjects were enrolled into the Supportive Care Group; however, 1 subject dropped before their baseline assessment, and 2 were unable to complete the measure in session. 55 subjects were enrolled into the CogSMART-PD group; however, 1 subject was unable to complete the measure in session.
11.76 seconds
STANDARD_DEVIATION 3.73 • n=54 Participants • 54 subjects were enrolled into the Supportive Care Group; however, 1 subject dropped before their baseline assessment, and 2 were unable to complete the measure in session. 55 subjects were enrolled into the CogSMART-PD group; however, 1 subject was unable to complete the measure in session.
12.01 seconds
STANDARD_DEVIATION 4.30 • n=105 Participants • 54 subjects were enrolled into the Supportive Care Group; however, 1 subject dropped before their baseline assessment, and 2 were unable to complete the measure in session. 55 subjects were enrolled into the CogSMART-PD group; however, 1 subject was unable to complete the measure in session.
Baseline Medication
685.26 milligrams
STANDARD_DEVIATION 445.71 • n=53 Participants • 54 subjects enrolled in the Supportive Care group; however, 1 subject's medication info was missing. 55 subjects enrolled in the CogSMART-PD group; however, 1 subject dropped before their baseline assessment.
764.17 milligrams
STANDARD_DEVIATION 483.10 • n=54 Participants • 54 subjects enrolled in the Supportive Care group; however, 1 subject's medication info was missing. 55 subjects enrolled in the CogSMART-PD group; however, 1 subject dropped before their baseline assessment.
725.09 milligrams
STANDARD_DEVIATION 464.46 • n=107 Participants • 54 subjects enrolled in the Supportive Care group; however, 1 subject's medication info was missing. 55 subjects enrolled in the CogSMART-PD group; however, 1 subject dropped before their baseline assessment.

PRIMARY outcome

Timeframe: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group. Therefore, 45 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started and 2 dropped during group. Therefore, 50 completed measure.

The WAIS-IV Matrix Reasoning test is a validated, objective measure of executive function. Scaled scores range from 0 to 26. Higher scores indicate better executive function. Scores reported below are change scores.

Outcome measures

Outcome measures
Measure
Supportive Care
n=45 Participants
Support Group for PD Supportive Care: Support Group for persons with PD
CogSMART-PD
n=50 Participants
Cognitive Rehabilitation for PD CogSMART-PD: Cognitive Rehabilitation for persons with PD
Wechsler Adult Intelligence Scale-IV (WAIS-IV) Matrix Reasoning Test Total Scaled Score
0.22 score on a scale
Standard Deviation 2.35
0.42 score on a scale
Standard Deviation 2.43

SECONDARY outcome

Timeframe: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group. Therefore, 45 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started and 2 dropped during group. Therefore, 50 completed measure.

D-KEFS: 20 Questions Test measures executive function. The range of scores is 1 - 19 with a higher score representing better executive function. Scores reported below are change scores.

Outcome measures

Outcome measures
Measure
Supportive Care
n=45 Participants
Support Group for PD Supportive Care: Support Group for persons with PD
CogSMART-PD
n=50 Participants
Cognitive Rehabilitation for PD CogSMART-PD: Cognitive Rehabilitation for persons with PD
Delis-Kaplan Executive Functioning System (D-KEFS): 20 Questions Test Total Questions Asked Scaled Score
-0.09 score on a scale
Standard Deviation 2.70
1.06 score on a scale
Standard Deviation 3.15

SECONDARY outcome

Timeframe: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group. Therefore, 45 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started, 2 dropped during group, and 1 was missing info. Therefore, 49 completed measure.

The measure examines self-reported change in cognition over time. Scores range from 16 - 80, with higher scores indicating worse functioning (or more cognitive decline). Scores reported below are change scores.

Outcome measures

Outcome measures
Measure
Supportive Care
n=45 Participants
Support Group for PD Supportive Care: Support Group for persons with PD
CogSMART-PD
n=49 Participants
Cognitive Rehabilitation for PD CogSMART-PD: Cognitive Rehabilitation for persons with PD
Informant Questionnaire on Cognitive Decline in the Elderly-Self Report (IQCODE-SR) Total Score
-5.51 score on a scale
Standard Deviation 7.84
-8.86 score on a scale
Standard Deviation 8.19

SECONDARY outcome

Timeframe: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group. Therefore, 45 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started, 2 dropped during group, and 2 were missing info. Therefore, 48 completed measure.

CPSA measures cognitive problems and memory strategy use. The range for scores is 0 - 90, with higher scores indicating higher frequency of using memory and thinking strategies. Scores reported below are change scores.

Outcome measures

Outcome measures
Measure
Supportive Care
n=45 Participants
Support Group for PD Supportive Care: Support Group for persons with PD
CogSMART-PD
n=48 Participants
Cognitive Rehabilitation for PD CogSMART-PD: Cognitive Rehabilitation for persons with PD
Cognitive Problems and Strategies Assessment (CPSA) Memory Strategies Use Score
-0.24 score on a scale
Standard Deviation 11.16
10.17 score on a scale
Standard Deviation 16.96

SECONDARY outcome

Timeframe: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group, 5 declined a caregiver, and 1 was missing info. 39 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started, 2 dropped during group, 2 were missing info, and 4 declined a caregiver. 44 completed measure.

IQCODE is a self-report questionnaire for caregivers that measures possible dementia and cognitive decline of the patient. The range for scores is 26 - 130, with higher score representing worse functioning/higher cognitive decline in the patient. Scores reported below are change scores.

Outcome measures

Outcome measures
Measure
Supportive Care
n=39 Participants
Support Group for PD Supportive Care: Support Group for persons with PD
CogSMART-PD
n=44 Participants
Cognitive Rehabilitation for PD CogSMART-PD: Cognitive Rehabilitation for persons with PD
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) Total Score
-4.49 score on a scale
Standard Deviation 7.03
-10.46 score on a scale
Standard Deviation 12.55

SECONDARY outcome

Timeframe: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group. Therefore, 45 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started and 2 dropped during group. Therefore, 50 completed measure.

MIST measures prospective memory. The range for scores is 0 - 48 with a higher score representing better prospective memory. Scores reported below are change score.

Outcome measures

Outcome measures
Measure
Supportive Care
n=45 Participants
Support Group for PD Supportive Care: Support Group for persons with PD
CogSMART-PD
n=50 Participants
Cognitive Rehabilitation for PD CogSMART-PD: Cognitive Rehabilitation for persons with PD
Memory for Intention Test (MIST) Total Score
4 score on a scale
Standard Deviation 5.43
2.82 score on a scale
Standard Deviation 6.87

SECONDARY outcome

Timeframe: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group. Therefore, 45 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started, 2 dropped during group, and 1 was missing info. Therefore, 49 completed measure.

WHOQOL-BREF is a self-reported measure of quality of life. Transformed score for the psychological domain ranges from 0 to 100. Higher scores indicate better quality of life. Scores reported below are change scores.

Outcome measures

Outcome measures
Measure
Supportive Care
n=45 Participants
Support Group for PD Supportive Care: Support Group for persons with PD
CogSMART-PD
n=49 Participants
Cognitive Rehabilitation for PD CogSMART-PD: Cognitive Rehabilitation for persons with PD
World Health Organization Quality of Life (WHOQOL)-BREF Psychological Domain Transformed Score
4.02 score on a scale
Standard Deviation 11.60
0.04 score on a scale
Standard Deviation 9.85

SECONDARY outcome

Timeframe: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group. Therefore, 45 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started, 2 dropped during group, and 1 was missing info. Therefore, 49 completed measure.

The PDQ-39 is a patient-reported measure of health and quality life over a 1-month period in individuals with Parkinson's disease. Total scores range from 0 to 156. Higher scores indicate poorer quality of life. Scores reported below are change scores.

Outcome measures

Outcome measures
Measure
Supportive Care
n=45 Participants
Support Group for PD Supportive Care: Support Group for persons with PD
CogSMART-PD
n=49 Participants
Cognitive Rehabilitation for PD CogSMART-PD: Cognitive Rehabilitation for persons with PD
Parkinson's Disease Questionnaire-39 (PDQ-39) Total Score
-2.31 score on a scale
Standard Deviation 11.56
-2.69 score on a scale
Standard Deviation 10.27

SECONDARY outcome

Timeframe: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group, 5 declined a caregiver, and 2 were missing info. 38 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started, 2 dropped during group, 3 were missing info, and 4 declined a caregiver. 43 completed measure.

The NPI-Q is a self-reported measure of neuropsychiatric symptoms over a 1 month period and 1 year period. Total month scores range from 0 to 156. Higher scores indicate greater severity of neuropsychiatric symptoms. Scores reported below are change scores.

Outcome measures

Outcome measures
Measure
Supportive Care
n=38 Participants
Support Group for PD Supportive Care: Support Group for persons with PD
CogSMART-PD
n=43 Participants
Cognitive Rehabilitation for PD CogSMART-PD: Cognitive Rehabilitation for persons with PD
Neuropsychiatric Inventory-Questionnaire (NPI-Q) Total Month Score
1.82 score on a scale
Standard Deviation 6.63
-2.30 score on a scale
Standard Deviation 9.15

Adverse Events

Supportive Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

CogSMART-PD

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Supportive Care
n=55 participants at risk
Support Group for PD Supportive Care: Support Group for persons with PD
CogSMART-PD
n=55 participants at risk
Cognitive Rehabilitation for PD CogSMART-PD: Cognitive Rehabilitation for persons with PD
Surgical and medical procedures
Clinical Motor Exam
0.00%
0/55 • 3 years
1.8%
1/55 • Number of events 1 • 3 years

Other adverse events

Adverse event data not reported

Additional Information

Dr. Dawn Schiehser

VASDHS

Phone: 858-552-8585

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place